Recommendations from the French Neurogastroenterology Group for the diagnosis and management of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) (notice n° 1921312)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02202cam a2200301 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260329022616.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Benzi, Andy |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Recommendations from the French Neurogastroenterology Group for the diagnosis and management of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2025.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 96 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The French Neurogastroenterology Group (GFNG) initiated the drafting of recommendations for the diagnosis and management of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) in adults. A working group developed a total of 25 proposals based on the most recent data from the international scientific literature, addressing the following topics: definition, symptoms, risk factors, diagnostic modalities, and therapeutic approaches. Each statement was assessed using the GRADE methodology to determine its level of evidence (“high,” “moderate,” “low,” or “expert opinion”) and, where applicable, a level of recommendation (“strong,” “moderate,” “weak,” or “very weak”). The proposals were submitted to 22 experts for a two-round vote, in accordance with the Delphi method, resulting in consensus—with over 80% agreement— for 19 proposals on SIBO and 3 on IMO. One proposal on SIBO and 2 on IMO failed to reach consensus, reflecting the complexity of these conditions. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wuestenberghs, Fabien |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vitton, Véronique |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chambaz, Marion |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Roman, Sabine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Benech, Nicolas |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dainese, Raffaella |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Takoudju, Céline |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jouët, Pauline |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Raynaud, Jean-Jacques |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gourcerol, Guillaume |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Melchior, Chloé |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mion, François |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 32 | 6 | 2025-07-04 | p. 528-552 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/journal-hepato-gastro-oncologie-digestive-2025-6-page-528?lang=en&redirect-ssocas=7080">https://stm.cairn.info/journal-hepato-gastro-oncologie-digestive-2025-6-page-528?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux